Market Research Logo

PCR Markets: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets with Executive and Consultant Guides, Including Customized Forecasting and Analysis 2020 to 2024

PCR Markets: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets with Executive and Consultant Guides, Including Customized Forecasting and Analysis 2020 to 2024

Report Overview:

Are singleplex tests going to be obsolete? Will routine cancer screening become a reality? Will diagnostics move into the Physician’s Office or even the Home? Will digital PCR become the new lab standard?

Our facts and support = Your success.

The report forecasts the market size out to 2024 with the only analysis available that breaks out Singleplex and Multiplex testing markets. PCR has proved itself in the market. And the new generation of PCR, digital PCR promises to keep that success going. New levels of sensitivity have implications for Liquid Biopsy and Cancer Screening markets. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success.

Our research makes you the expert in your organization. Get our research team working for you by ordering this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to a wider license. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.


1. Introduction and Market Definition
1.1 What are PCR Technologies?
1.2 PCR – New Horizons
1.2.1 PCR and Syndromic Testing
1.3 Market Definition
1.3.1 Market Size
1.3.2 Currency
1.3.3 Years
1.4 Methodology
1.4.1 Authors
1.4.2 Sources
1.5 U.S. Medical Market and laboratory Testing - Perspective
1.4.1 U.S. Medicare Expenditures for Laboratory Testing
2. PCR – Guide to PCR Technologies
2.0 PCR
2.1 Concepts
2.1.1 Method
2.2 Applications
2.2.1 Finding Specific DNA
2.2.2 Measuring DNA
2.2.3 Medical and diagnostic applications
2.2.3.1 Carrier, prenatal and tissue typing
2.2.3.2 Cancer Diagnosis and Management
2.2.3.3 Infectious disease – New Levels of Accuracy and Sensitivity
2.2.3.4 Forensic applications
2.2.3.5 Science and Research
2.3 PCR – Advantages and Disadvantages
2.4 Different Types of PCR
2.4.1 Simple Changes
2.4.1.1 Multiplex-PCR
2.4.1.2 VNTR PCR
2.4.1.3 Asymmetric PCR
2.4.1.4 Long PCR
2.4.1.5 Nested PCR
2.4.1.6 Quantitative PCR
2.4.1.7 Hot-start PCR
2.4.1.8 Touchdown PCR
2.4.1.9 Assembly PCR
2.4.1.10 Colony PCR
2.4.1.11 Suicide PCR
2.4.1.12 Cold PCR
2.4.2 Digital PCR
2.4.2.1 Droplet Digital PCR
2.4.2.2 Comparison between dPCR and Real-Time PCR (qPCR)
2.4.2.3 Digital PCR in Use
2.4.2.4 Digital PCR Commercial History
2.4.3 Isothermal PCR
3. Industry Overview
3.1 Players in a Dynamic Market
3.1.1 Academic Research Lab
3.1.2 Diagnostic Test Developer
3.1.3 Genomic Instrumentation Supplier
3.1.3.1 Cell Separation and Viewing Instrumentation Supplier
3.1.4 Pharmaceutical/Reagent Supplier
3.1.5 Independent Testing Lab
3.1.6 Public National/regional lab
3.1.7 Hospital lab
3.1.8 Physician Lab
3.1.9 Audit Body
3.1.10 Certification Body
4. Market Trends
4.1 Factors Driving Growth
4.1.1 A New Standard
4.1.2 Down the Curve We Go
4.1.3 Multiplexing
4.1.4 Syndromic Diagnostics Looks Unstoppable
4.1.5 The Genetic Blizzard
4.2 Factors Limiting Growth
4.2.1 The Cost Curve
4.2.2 The Other Guys
4.2.3 Systemic Roadblocks
4.3 Diagnostic Technology Development
4.3.1 The Instrumentation Curve
4.3.2 Shifting Role of Diagnostics
4.3.3 Diagnostics Moves Out of the Lab
4.3.3.1 What About Imaging?
4.3.4 Disruption Looms
4.3.5 The Next Five Years
5. PCR Recent Developments
5.1 Recent Developments – Importance and How to Use This Section
5.1.1 Importance of These Developments
5.1.2 How to Use This Section
QIAGEN Plans for Next-Generation Digital PCR Systems
Bioneer HIV-1 Dx Kit Gets Korea FDA Approval
New PCR Technology: Transfer-PCR (tPCR) Applications
NimaGen Licenses PCR Tech from Salisbury NHS Foundation Trust
Natera Applies Massively Multiplexed PCR to Kidney Transplants
Paragon Genomics, MGI Tech Form Distribution Alliance
Synlab Pharma, Biotype Collaborate on Gastrointestinal, Endometrial Cancers
Qiagen, NeuMoDx Ink Partnership, Merger Agreement
Bruker to Acquire Majority in Hain Lifescience GmbH
Curetis to Cut 30 Percent of Workforce as Part of Strategic Restructuring
Cancer Early Detection Firm Ark Launches With $40M Series A Investment
PredictImmune Wins £100K Grant for Study of IBD Prognostic
Biocartis, AstraZeneca Partner on European Lung Cancer Biomarker Study
llumina Ventures Leads €16M Series A Investment in Digital PCR Firm Stilla Technologies
Bio-Rad Wins USDA Food Safety Testing Contract
Luminex, XCR Diagnostics Sign Nucleic Acid Amplification Tech Licensing Deal
6. Profiles of Key PCR Companies
Abbott Diagnostics (Alere)
Accelerate Diagnostics
Agilent
Alveo Technologies
Applied BioCode
Atlas Genetics
Aus Diagnostics
BD Diagnostics
Biocartis
BioFire Diagnostics
bioMérieux
Bioneer
Bio-Rad Laboratories
Bosch Healthcare Solutions GmbH
Bruker
Cepheid
Curetis
Diagenode Diagnostics
Diasorin
Fluidigm
Fusion Genomics.
GenePOC Diagnostics
GenMark Dx
Hologic
Invetech
Janssen Diagnostics
Karius
Lexigene
Luminex
Mesa Biotech
Mobidiag
Nanomix
Panagene
Precipio
Primerdesign
Prominex
Qiagen (Statdx)
Quantumdx
Roche Molecular Diagnostics
Seegene
Stilla Technologies
Siemens Healthineers (Fast Track Diagnostics)
SkylineDx
T2 Biosystems
Thermo Fisher
Veramarx
XCR Diagnostics
7. The PCR Markets
7.1 PCR – Global Market Overview by Country
7.1.1 Table – Global Market by Country
7.1.2 Chart - Global Market by Country
8. Global PCR Markets – By Application
8.1 Global Market by Application - Overview
8.1.1 Table – Global Market by Application
8.1.2 Chart – Global Market by Application – 2019/2024 Comparison
8.1.3 Chart – Global Market by Application – 2019
8.1.4 Chart – Global Market by Application –2024
8.1.4 Chart – Global Market by Application – Share by Year
8.2 PCR Clinical Multiplex
8.2.1 Table PCR Clinical Multiplex Testing – by Country
8.2.2 Chart - PCR Clinical Multiplex Testing Growth
8.3 PCR Clinical Singleplex
8.3.1 Table PCR Clinical Singleplex Testing – by Country
8.3.2 Chart - PCR Clinical Singleplex Testing Growth
8.4 PCR Research
8.4.1 Table PCR Research – by Country
8.4.2 Chart - PCR Research Growth
8.5 PCR Forensic
8.5.1 Table PCR Forensic – by Country
8.5.2 Chart - PCR Forensic Growth
8.6 PCR Other
8.6.1 Table PCR Other – by Country
8.6.2 Chart - PCR Other Growth
9. Global PCR Markets – By Technology
9.1 Global Market by Technology - Overview
9.1.1 Table – Global Market by Technology
9.1.2 Chart – Global Market by Technology – 2019/2024 Comparison
9.1.3 Chart – Global Market by Technology – 2019
9.1.4 Chart – Global Market by Technology –2024
9.1.4 Chart – Global Market by Technology – Share by Year
9.2 qPCR
9.2.1 Table qPCR – by Country
9.2.2 Chart - qPCR Growth
9.3 dPCR
9.3.1 Table dPCR – by Country
9.3.2 Chart - dPCR Growth
9.4 Other PCR
9.4.1 Table Other PCR – by Country
9.4.2 Chart - Other PCR Growth
Appendices
I. United States Medicare System: 2018 Clinical Laboratory Fees Schedule – National Limit and
Midpoint
II. FDA Approved Microbial Tests
Table of Tables
Table 1 List of Cancers by Mortality
Table 2 Lab Spending 2014 to 2024
Table 3 Market Players by Type
Table 4 Five Factors Driving Growth
Table 5 Three Factors Limiting Growth
TABLE 6 - GLOBAL PCR MARKET BY REGION
TABLE 7 GLOBAL MARKET BY APPLICATION
TABLE 8 PCR CLINICAL MULTIPLEX BY COUNTRY
TABLE 9 PCR CLINICAL SINGLEPLEX BY COUNTRY
TABLE 10 PCR RESEARCH BY COUNTRY
TABLE 11 PCR FORENSIC BY COUNTRY
TABLE 12 PCR OTHER BY COUNTRY
TABLE 13 GLOBAL MARKET BY TECHNOLOGY
TABLE 14 QPCR BY COUNTRY
TABLE 15 DPCR BY COUNTRY
TABLE 16 OTHER PCR BY COUNTRY
Table 17 2018 Clinical Lab Fee Schedule
Table of Figures
Figure 1 Cancer Death Rates – USA, CDC
Figure 2 Clinical Lab Spending 2014 to 2024
Figure 3 The PCR Process
Figure 4 Creation of Sample Droplets for Digital PCR
Figure 5 Comparing Syndromic and Targeted Testing
Figure 6 Comparing The New Diagnostics and Traditional Testing
Figure 7 Growth rates of DiagnosticTechnologies
Figure 8 2018 Global Market Density Chart
Figure 9 PCR Market by Application - 2019 vs. 2024
FIGURE 10 PCR MARKET 2019
FIGURE 11 PCR MARKET 2024
FIGURE 12 APPLICATION SHARE BY YEAR
FIGURE 13 PCR CLINICAL MULTIPLEX TESTING GROWTH
FIGURE 14 PCR CLINICAL SINGLEPLEX TESTING GROWTH
FIGURE 15 PCR RESEARCH GROWTH
FIGURE 16 PCR FORENSIC GROWTH
FIGURE 17 PCR OTHER GROWTH
FIGURE 18 PCR MARKET BY TECHNOLOGY - 2019 VS. 2024
FIGURE 19 PCR MARKET 2019

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook